Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Water-Electrolyte Imbalance 1Warts 1Squamous Cell Carcinoma of Head and Neck 1Mouth Neoplasms 1Head and Neck Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Brain Neoplasms 1Barrett Esophagus 1Adenocarcinoma 1Acid-Base Imbalance 1

Interventions

Oxaliplatin 46Gemcitabine 45Fluorouracil 40Capecitabine 31pembrolizumab 29Leucovorin 29Docetaxel 27Cisplatin 25Paclitaxel 23Irinotecan 18Carboplatin 18Bevacizumab 18130-nm albumin-bound paclitaxel 17Pemetrexed 15Albumin-Bound Paclitaxel 15Radiotherapy 14Nivolumab 12Ramucirumab 11Cyclophosphamide 11Trastuzumab 8Erlotinib Hydrochloride 8Taxes 7Radiosurgery 7Drug Therapy 7cemiplimab 6zolbetuximab 5trastuzumab deruxtecan 5regorafenib 5durvalumab 5Sorafenib 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Adenocarcinoma × gluconic acid × Clear all
NCT01984580 2013-11-14

Effect of Zinc on Barrett's Metaplasia

Main Line Health

Phase 1 Unknown
120 enrolled
Gastrointestinal

Adenocarcinoma, Barrett Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡